320 related articles for article (PubMed ID: 22327790)
1. Oropharyngeal cancer - is it time to change management according to human papilloma virus status?
Mehanna H; Olaleye O; Licitra L
Curr Opin Otolaryngol Head Neck Surg; 2012 Apr; 20(2):120-4. PubMed ID: 22327790
[TBL] [Abstract][Full Text] [Related]
2. Human papilloma virus in locally advanced stage III/IV squamous cell cancer of the oropharynx and impact on choice of therapy.
Ihloff AS; Petersen C; Hoffmann M; Knecht R; Tribius S
Oral Oncol; 2010 Oct; 46(10):705-11. PubMed ID: 20843732
[TBL] [Abstract][Full Text] [Related]
3. What is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer?
Urban D; Corry J; Rischin D
Cancer; 2014 May; 120(10):1462-70. PubMed ID: 24578320
[TBL] [Abstract][Full Text] [Related]
4. The changing aetiology of head and neck cancer: the role of human papillomavirus.
Evans M; Powell NG
Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):538-46. PubMed ID: 20584591
[TBL] [Abstract][Full Text] [Related]
5. Management of human papillomavirus-positive and human papillomavirus-negative head and neck cancer.
Mehra R; Ang KK; Burtness B
Semin Radiat Oncol; 2012 Jul; 22(3):194-7. PubMed ID: 22687943
[TBL] [Abstract][Full Text] [Related]
6. Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus.
Ernster JA; Sciotto CG; O'Brien MM; Finch JL; Robinson LJ; Willson T; Mathews M
Laryngoscope; 2007 Dec; 117(12):2115-28. PubMed ID: 17891052
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.
Ang KK; Sturgis EM
Semin Radiat Oncol; 2012 Apr; 22(2):128-42. PubMed ID: 22385920
[TBL] [Abstract][Full Text] [Related]
8. Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy.
Huang SH; Perez-Ordonez B; Liu FF; Waldron J; Ringash J; Irish J; Cummings B; Siu LL; Kim J; Weinreb I; Hope A; Gullane P; Brown D; Shi W; O'Sullivan B
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):276-83. PubMed ID: 20950953
[TBL] [Abstract][Full Text] [Related]
9. HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech Republic.
Tachezy R; Klozar J; Saláková M; Smith E; Turek L; Betka J; Kodet R; Hamsíková E
Oral Dis; 2005 May; 11(3):181-5. PubMed ID: 15888110
[TBL] [Abstract][Full Text] [Related]
10. HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behavior.
Kraft S; Faquin WC; Krane JF
Am J Surg Pathol; 2012 Mar; 36(3):321-30. PubMed ID: 22301491
[TBL] [Abstract][Full Text] [Related]
11. HPV-Associated Head and Neck Cancer: Unique Features of Epidemiology and Clinical Management.
Maxwell JH; Grandis JR; Ferris RL
Annu Rev Med; 2016; 67():91-101. PubMed ID: 26332002
[TBL] [Abstract][Full Text] [Related]
12. HPV-related oropharyngeal cancers: from pathogenesis to new therapeutic approaches.
Tornesello ML; Perri F; Buonaguro L; Ionna F; Buonaguro FM; Caponigro F
Cancer Lett; 2014 Sep; 351(2):198-205. PubMed ID: 24971935
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
Dahlstrom KR; Anderson KS; Field MS; Chowell D; Ning J; Li N; Wei Q; Li G; Sturgis EM
Cancer; 2017 Dec; 123(24):4886-4894. PubMed ID: 28898394
[TBL] [Abstract][Full Text] [Related]
14. Human papilloma virus-related oropharyngeal cancer: opportunities and challenges in dysphagia management.
Goldsmith TA; Roe JW
Curr Opin Otolaryngol Head Neck Surg; 2015 Jun; 23(3):185-90. PubMed ID: 25943965
[TBL] [Abstract][Full Text] [Related]
15. Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer.
Nichols AC; Finkelstein DM; Faquin WC; Westra WH; Mroz EA; Kneuertz P; Begum S; Michaud WA; Busse PM; Clark JR; Rocco JW
Clin Cancer Res; 2010 Apr; 16(7):2138-46. PubMed ID: 20233885
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status.
Huang SH; Waldron JN; Milosevic M; Shen X; Ringash J; Su J; Tong L; Perez-Ordonez B; Weinreb I; Bayley AJ; Kim J; Hope A; Cho BC; Giuliani M; Razak A; Goldstein D; Shi W; Liu FF; Xu W; O'Sullivan B
Cancer; 2015 Feb; 121(4):545-55. PubMed ID: 25336438
[TBL] [Abstract][Full Text] [Related]
17. 'Good cancer gone bad': a narrative review of HPV oropharyngeal cancer and potential poor outcomes.
Alabi O; O'Neill JP
Eur Arch Otorhinolaryngol; 2020 Aug; 277(8):2185-2191. PubMed ID: 32333138
[TBL] [Abstract][Full Text] [Related]
18. Incidence of human papillomavirus-related oropharyngeal cancer and outcomes after chemoradiation in a population of heavy smokers.
Cerezo L; López C; de la Torre A; Suárez D; Hervás A; Ruiz A; Ballestín C; Martín M; Sandoval P
Head Neck; 2014 Jun; 36(6):782-6. PubMed ID: 23616290
[TBL] [Abstract][Full Text] [Related]
19. The increasing clinical relevance of human papillomavirus type 16 (HPV-16) infection in oropharyngeal cancer.
Shaw R; Robinson M
Br J Oral Maxillofac Surg; 2011 Sep; 49(6):423-9. PubMed ID: 20727631
[TBL] [Abstract][Full Text] [Related]
20. Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer.
Dahlstrom KR; Li G; Hussey CS; Vo JT; Wei Q; Zhao C; Sturgis EM
Cancer; 2015 Oct; 121(19):3455-64. PubMed ID: 26094818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
